Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory
All Press Releases for March 04, 2010 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Trutek Corp. Embarks on Six-Country International Launch of Innovative Allergy Combatant
Drug and Side-Effect Free NasalGuard Unveils in Japan 
x-small text small text medium text large text


    BRIDGEWATER, NJ, March 04, 2010 /24-7PressRelease/ -- Trutek Corp., the exclusive marketer, distributor and licensor for NasalGuard , a topical gel used to prevent the inhalation of airborne allergens, and its patented technology, has kicked off its six-country global launch of NasalGuard with an impressive publicity campaign in Japan featuring Japan's top models and actors supporting the push with public appearances as well as personal blog posts. Named "Crystal Veil" in Japan, the technology will be marketed by Japanese distributor Nitto Pharmaceutical Industries, Ltd., and their sub-distributor Eisai Co. Ltd., who held a talk show kick-off event on January 19, 2010 focusing on how to deal with hay fever.
Created by prominent inventor Ashok Wahi, NasalGuard is currently being marketed as an extension of the well known Chloraseptic brand under the name AllergenBlock in the U.S. and Canada. The drug-free invisible gel is applied to the outer nose and upper lip and blocks airborne allergens from entering the nasal passages by forming an invisible shield that attracts them like flypaper does insects.
The technology behind the product is what truly makes it unique-- NasalGuard has a positive electro-static charge which is opposite to the negative charge characteristic to allergens. Since the product is drug-free it has no side effects and will not make the user drowsy which is characteristic of many over-the-counter allergy drug products.
"We're thrilled to start off our international roll-out of NasalGuard in Japan with such an overwhelming display of support," said Ashok Wahi, President of Trutek Corp. "Japan is the first of six countries we're set to launch the NasalGuard technology in and we're truly excited to bring a product that helps improve people's lives by solving a common real world health-related concern to an international market."
Eisai Co. Ltd. (Japan) is also currently engaging in a Web-based grassroots promotion of Crystal Veil on the company site which asks one hundred Crystal Veil users to blog about their experience with the product.
For more information on Nasalguard and Trutek Corp., please contact dporter@nasalguard.com
About Trutek Corp.
Trutek Corp., based in Somerville, NJ, was founded in 1995 and is dedicated to providing solutions to problems common to everyday life. Trutek is the owner of the technology and intellectual property for the NasalGuard product line. Trutek currently has an extensive pipeline of additional technologies and products, and is seeking qualified licensees and joint venture partners. For more information, contact dporter@nasalguard.com


NasalGuard is a registered trademark of Trutek Corp. All rights reserved.

Chloraseptic and AllergenBlock are registered trademarks of Prestige Brands, Inc.

Crystal Veil is a trademark of Eisai Co. Ltd.; Japan


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #


Read more Press Releases from Sue Hart:
Other Press Release Headlines:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Sue Hart
R&J Public Relations

Account Coordinator
1140 Rt 22 East
Bridgewater, NJ
USA 08807
Voice: 908-722-5757
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.